This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Lonza Inc.. Active years: 2020-2022.
Company Filing History:
Years Active: 2020-2022
Title: James Budge: Innovator in Lipid Metabolism and Protein Production
Introduction
James Budge is a notable inventor based in Canterbury, GB. He has made significant contributions to the field of biotechnology, particularly in the modulation of lipid metabolism for enhanced protein production. With a total of 2 patents, his work is paving the way for advancements in recombinant products and biologics.
Latest Patents
James Budge's latest patents focus on the modulation of lipid metabolism to improve the production and quality of recombinant products. The methods and compositions he has developed include introducing lipid metabolism modulators to cells or cell-free systems. His innovations also encompass engineered cells that exhibit improved production capacity and product quality, along with methods for engineering such cells and preparations comprising the products derived from them.
Career Highlights
James Budge is currently associated with Lonza Inc., a leading company in the life sciences sector. His work at Lonza has allowed him to explore and implement cutting-edge techniques in biotechnology, contributing to the development of next-generation biologics.
Collaborations
James has collaborated with notable colleagues, including Christopher Mark Smales and Tanya Jeane Knight. These partnerships have further enriched his research and development efforts in the field.
Conclusion
James Budge's innovative work in lipid metabolism and protein production exemplifies the impact of biotechnology on modern science. His contributions are essential for advancing the quality and efficiency of recombinant products.